Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search

Search

  1. Home
  2. Homepage
Filter by
  • Filter by
  • Remove this filter Country: Asia
  • Remove this filter Public health area: Threats and outbreaks
  • Infectious disease
    • Respiratory diseases (176)
    • Vaccine preventable diseases (166)
    • Influenza (143)
    • Mosquito-borne diseases (120)
    • Middle East respiratory syndrome coronavirus (100)
    • Coronavirus (100)
    • Poliomyelitis (95)
    • Zoonosis (66)
    • Food- and waterborne diseases (64)
    • Viral haemorrhagic fever (56)
    • Ebola haemorrhagic fever (51)
    • Zika virus disease (50)
    • Avian influenza virus (49)
    • Zoonotic influenza (49)
    • Measles (46)
    • Chikungunya virus disease (46)
    • West Nile virus infection (38)
    • Dengue (36)
    • Influenza in humans, avian origin (32)
    • Yellow fever (31)
    • Influenza A(H7N9) virus (28)
    • Legionnaires’ disease (27)
    • Influenza A (H9N2) (27)
    • Avian influenza in humans (26)
    • Rubella (25)
    • German measles (25)
    • Influenza in humans, seasonal (24)
    • Seasonal influenza (24)
    • Flu (24)
    • Viral hepatitis (20)
    • Hepatitis A (20)
    • Influenza in humans, swine origin (20)
    • Cholera (18)
    • Zika virus disease - Outbreak in the Americas (14)
    • Salmonellosis (8)
    • Botulism (7)
    • Tuberculosis (6)
    • Enterovirus (6)
    • Coxsackievirus (6)
    • Ebola outbreak - North Kivu, Ituri, DRC (6)
    • Pertussis (5)
    • Whooping cough (5)
    • Vibrio (4)
    • Multidrug-resistant tuberculosis (3)
    • Invasive meningococcal disease (3)
    • Paratyphoid fever (3)
    • Enteric fever (3)
    • Listeriosis (3)
    • Meningococcal disease (3)
    • Travel related infections (3)
    • Malaria (3)
    • Typhoid and paratyphoid fever (3)
    • Hand, foot and mouth disease (3)
    • Crimean-Congo haemorrhagic fever (2)
    • Influenza A(H5N1) virus (2)
    • Marburg virus diseases (2)
    • Marburg haemorrhagic fever (2)
    • Extensively drug-resistant tuberculosis (XDR-TB) (2)
    • Vector-borne disease (2)
    • Severe acute respiratory syndrome (SARS) (2)
    • Tick-borne diseases (2)
    • Plague (2)
    • Diphtheria (2)
    • Schistosomiasis (1)
    • Influenza A(H5N8) virus (1)
    • Gastrointestinal disease (1)
    • Hantavirus infection (1)
    • Snail fever (1)
    • Bilharziasis (1)
    • Nephropathia epidemica (1)
    • Haemorrhagic fever with renal syndrome (Puumala caused) (1)
    • Haemorrhagic fever (1)
    • Guillain-Barré syndrome (1)
    • Rabies (1)
    • Drug-resistant tuberculosis (1)
    • Methicillin-resistant Staphylococcus aureus (MRSA) (1)
    • Ebola outbreak - West Africa (1)
    • Healthcare-associated infections (1)
    • Rift Valley fever (1)
    • Mumps (1)
    • Hepatitis B (1)
    • Tularaemia (1)
    • Leptospirosis (1)
    • Sexually transmitted infections (1)
    • Tetanus (1)
    • Monkeypox (1)
  • Public health area
    • Threats and outbreaks (218)
    • Public health threat (218)
    • Outbreak (218)
    • Scientific advice (35)
    • Surveillance (30)
    • Determinant (12)
    • Migrant health (11)
    • Travellers' health (9)
    • Infectious diseases on aircrafts (9)
    • Mass gathering (8)
    • Epidemiology (4)
    • Health inequality (2)
    • Microbiology (1)
    • Prevention and control (1)
    • Public health response (1)
    • Reference laboratory (1)
    • Antimicrobial resistance (1)
    • Disease prevention (1)
    • Prophylaxis (1)
    • Control campaign (1)
    • Antibiotic resistance (1)
    • Pregnant women (1)
  • Country
    • Asia (218)
      • China (127)
      • Middle East (84)
      • Far East (17)
      • Southeastern Asia (11)
      • Western Asia (6)
      • Eastern Asia (2)
    • Europe (137)
    • Africa (66)
    • Americas (57)
    • European Neighbourhood Policy countries (21)
    • Pacific regions (13)
    • North America (10)
    • Oceania (3)
    • EU Candidate Countries (2)
    • Nothern Africa (1)
  • Type
    • Publication (168)
    • Surveillance report (96)
    • News (46)
    • Risk assessment (45)
    • Epidemiological update (37)
    • ECDC comment (5)
    • Data (2)
    • Map (2)
    • External link (2)
    • Peer-reviewed publication (1)
    • Table (1)
  • Page 1 of 22 // 218 Results found
    • Sort by:

Publication

Rapid risk assessment: Human fatality from highly pathogenic avian influenza A(H5N1) virus infection in Guangdong province, China

Risk assessment - 5 Jan 2012

Following reports of a human fatality due to highly pathogenic avian influenza A(H5N1) virus infection in China’s Guangdong province, the European Commission requested an update to the assessment of risk of human-to-human transmission occurring. ECDC does not consider that there is any change to the previous assessments that the risk for EU/EEA countries is very low.

120105_TER_RA_H5N1_China.pdf - EN - [PDF-1.22 MB]
  • Avian influenza virus
  • China
  • Influenza
  • Influenza A(H5N1) virus
  • Influenza in humans, avian origin
  • Public health threat

Publication

Risk assessment: Severe respiratory disease associated with a novel coronavirus, 26 September 2012

Risk assessment - 26 Sep 2012

Following the identification of a novel coronavirus in two patients, both having been in Saudi Arabia albeit three months apart, ECDC has prepared a rapid risk assessment to consider the risk to the public in the EU. A version of this risk assessment was shared with EU and EEA national public health competent bodies and WHO on 24 September.

Risk assessment: Severe respiratory disease associated with a novel coronavirus risk assessment, 26 September 2012 - EN - [PDF-1.25 MB]
  • Middle East respiratory syndrome coronavirus
  • Public health threat
  • Saudi Arabia
  • Scientific advice

Publication

Rapid risk assessment, update: Severe respiratory disease associated with a novel coronavirus

Risk assessment - 26 Nov 2012

CDC updated risk assessment concludes that in the absence of evidence of sustained person-to-person transmission outside of household settings, the current facts still point towards a hypothesis of a zoonotic or environmental source with occasional transmission to exposed humans. WHO does not advise any travel or trade restrictions at this point for KSA or Qatar.

cronavirus-risk-assessment-nov-2012.pdf - EN - [PDF-164.77 KB]
  • Public health threat
  • Qatar
  • Saudi Arabia
  • Scientific advice
  • Severe acute respiratory syndrome (SARS)

Publication

Rapid Risk Assessment: Severe respiratory disease associated with a novel coronavirus

Risk assessment - 7 Dec 2012

New and noteworthy in this update: the retrospective identification of novel coronavirus in biological samples from two fatal cases in Jordan (April 2012) and the results of a joint ECDC/WHO survey which confirms that EU/EEA Member States have an adequate capacity to detect novel coronavirus through their network of national reference laboratories: 18 of 30 in EU/EEA countries are capable of confirming positive screened samples by either ORF1b RT-PCR or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis.

20121207-Novel-coronavirus-rapid-risk-assessment.pdf - EN - [PDF-552.18 KB]
  • Influenza
  • Jordan
  • Middle East respiratory syndrome coronavirus
  • Public health threat
  • Scientific advice
  • Severe acute respiratory syndrome (SARS)

Publication

RRA: Severe respiratory disease associated with MERS-CoV, 4th update; 17 May 2013

Risk assessment - 17 May 2013

This fourth update of the rapid risk assessment of severe respiratory disease associated with a novel coronavirus (MERS-CoV) was produced in relation to 22 additional cases of laboratory-confirmed infections reported in the last two months.

risk-assessment-middle-east-respiratory-syndrome-coronavirus-MERS-CoV-17-may-2013.pdf - EN - [PDF-705.14 KB]
  • Middle East
  • Middle East respiratory syndrome coronavirus
  • Public health threat
  • Saudi Arabia
  • Scientific advice

Publication

Human infection with a novel avian influenza virus, A(H7N9), China - 2nd update, 8 May 2013

Risk assessment - 8 May 2013

This second update to ECDC's initial risk assessment concludes that the risk of the disease spreading to Europe via humans or through poultry is still low at this time.

influenza-A(H7N9)-China-rapid-risk-assessment-8-may-2013.pdf - EN - [PDF-850.93 KB]
  • Avian influenza virus
  • China
  • Influenza
  • Influenza A(H7N9) virus
  • Influenza in humans, avian origin
  • Public health threat
  • Scientific advice

Publication

Rapid risk assessment on influenza A(H7N9) China, 12 April 2013

Risk assessment - 12 Apr 2013

On 31 March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) influenza virus isolated from three unlinked cases of severe respiratory disease in eastern China. This is the first time that human infection with avian influenza virus A(H7N9) has been identified.
Since then, human cases have continued to be reported from eastern China. As of 11 April, there were 38 laboratory-confirmed cases including ten deaths reported from four bordering provinces with a concentration of cases in and around Shanghai. Cases occur sporadically, without obvious epidemiological links. There is currently no confirmed human-to-human transmission.

influenza-A(H7N9)-China-rapid-risk-assessment-4-april-2013.pdf - EN - [PDF-429.73 KB]
  • Avian influenza virus
  • China
  • Influenza
  • Influenza A(H7N9) virus
  • Public health threat
  • Scientific advice

Publication

Rapid risk assessment: Severe respiratory disease associated with a novel influenza A virus, A(H7N9) China

Risk assessment - 3 Apr 2013

On 31 March 2013, the Chinese authorities announced the identification of a novel influenza A virus, A(H7N9), in three seriously ill people from two provinces presenting with respiratory infections. So far, no epidemiological link has been identified between those three patients. When testing for the influenza virus, the Chinese Center for Disease Control and Prevention identified genes from both A(H7N9) and A(H9N2) viruses, thus indicating a novel reassortant avian influenza A virus. In its initial assessment of the situation, the ECDC rapid risk assessment concludes that the risk of the spread of the virus in Europe can be considered low at this stage.

AH7N9-China-rapid-risk-assessment.pdf - EN - [PDF-682.47 KB]
  • Avian influenza virus
  • China
  • Influenza
  • Influenza A(H7N9) virus
  • Influenza in humans, avian origin
  • Public health threat

Publication

Communicable disease threats report 3-9 February 2013, week 6

Surveillance report - 8 Feb 2013

From 3 February to 9 February 2013, ECDC monitored several on-going public health threats within and outside the European Union

communicable-disease-threats-report-9-feb-2013.pdf - EN - [PDF-261.94 KB]
  • Dengue
  • Finland
  • Influenza
  • Measles
  • Pakistan
  • Poliomyelitis
  • Portugal
  • Public health threat
  • Rubella

Publication

Rapid Risk Assessment: Cyclovirus in cerebrospinal fluid of patients with central nervous system infection

Risk assessment - 8 Jul 2013

​This assessment is related to the publication of the identification of a new cyclovirus species, tentatively named cyclovirus-Vietnam (CyCV-VN), in cerebrospinal fluid of patients with acute central nervous system infection. However, there are insufficient data to assess the risk for disease occurrence in humans or potential of human-to-human transmission. Further studies should be encouraged in Europe and elsewhere to investigate the possible pathogenicity, epidemiology, and transmission patterns of cycloviruses.

rapid-risk-assessment-Cyclovirus-final.pdf - EN - [PDF-420.38 KB]
  • Epidemiology
  • Public health threat
  • Scientific advice
  • Vietnam

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
    • Partnerships and networks
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2019
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us